Literature DB >> 2537618

The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.

R W Mason1, D Wilcox, P Wikstrom, E N Shaw.   

Abstract

The major active forms of cathepsins B and L were identified in Kirsten-virus-transformed mouse fibroblasts by the use of a specific radiolabelled inhibitor, benzyloxycarbonyl-Tyr(-125I)-Ala-CHN2. No other proteins were labelled, demonstrating the specificity of this inhibitor for cysteine proteinases. Cathepsins B and L were distinguished by the use of specific antibodies. One active form of cathepsin B, Mr 33,000-35,000, and two active forms of cathepsin L, Mr 30,000 and 23,000, were identified. The intracellular precursors of these proteins had higher Mr values of 39,000 and 36,000 for cathepsins B and L respectively, as shown by pulse-chase experiments with [35S]methionine-labelled proteins. These did not react with the inhibitor under our culture conditions. The precursor of cathepsin L was secreted whereas the precursor of cathepsin B was not, demonstrating that secretions of the two enzymes are regulated differently. In contrast with results found previously for the purified protein [Mason, Gal & Gottesman (1987) Biochem. J. 248, 449-454], the secreted precursor form of cathepsin L did not react with the inhibitor either, indicating that it is not active and therefore, as such, cannot be directly involved in tumour invasion. The secreted protein did react with the inhibitor when incubated at pH 3.0, showing that the protein can be activated, although this did not occur under our culture conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537618      PMCID: PMC1135546          DOI: 10.1042/bj2570125

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Lysosomes.

Authors:  R T Dean; A J Barrett
Journal:  Essays Biochem       Date:  1976       Impact factor: 8.000

2.  A comparison of the behavior of chymotrypsin and cathepsin B towards peptidyl diazomethyl ketones.

Authors:  H Watanabe; G D Green; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1979-08-28       Impact factor: 3.575

Review 3.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption.

Authors:  J M Delaissé; Y Eeckhout; G Vaes
Journal:  Biochem Biophys Res Commun       Date:  1984-12-14       Impact factor: 3.575

5.  Biochemical and immunological studies of lysosomal and related proteinases in health and disease.

Authors:  A R Poole; J S Mort
Journal:  J Histochem Cytochem       Date:  1981-03       Impact factor: 2.479

6.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases.

Authors:  E Shaw; R T Dean
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

8.  Cathepsin B-related proteases in the insulin secretory granule.

Authors:  K Docherty; J C Hutton; D F Steiner
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

9.  Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts.

Authors:  M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 10.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more
  28 in total

1.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.

Authors:  H Angliker; P Wikstrom; H Kirschke; E Shaw
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts.

Authors:  A Salminen; M M Gottesman
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

Review 4.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

5.  The synthesis, kinetic characterization and application of biotinylated aminoacylchloromethanes for the detection of chymotrypsin and trypsin-like serine proteinases.

Authors:  G Kay; J R Bailie; I M Halliday; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

6.  Cathepsins D, B, and L in transformed human breast epithelial cells.

Authors:  T T Lah; G Calaf; E Kalman; B G Shinde; R Somers; S Estrada; E Salero; J Russo; I Daskal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

8.  Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation.

Authors:  Elizabeth M Duncan; Tara L Muratore-Schroeder; Richard G Cook; Benjamin A Garcia; Jeffrey Shabanowitz; Donald F Hunt; C David Allis
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

9.  Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.

Authors:  J M Delaissé; P Ledent; G Vaes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

10.  Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.

Authors:  R Xing; R W Mason
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.